TerminatedNCT00423189
Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration
PHASE4 · 7 planned enrolment
- Countries listed
- 1
- Registry update
- March 4, 2016
immortal.lifeTrial registrations containing the exact intervention label Ranibizumab (Lucentis).
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE4 · 7 planned enrolment
PHASE2 · 40 planned enrolment